Repositioning of the offer and restructuring show their first positive effects.

Details about funding agreement and proposed combination with DMS Group.

Several partnership agreements signed in Europe, strengthening Intrasense positions on its historical market.

Issue of Convertible Bonds with Share (OCA) for a maximum nominal amount of 3.5 millions euros over 3 years.

Both companies are finalizing the contribution agreement and the exchange parity.

Worldwide launching of the latest version of Myrian^® during the Chinese hospital information systems tradeshow.

This 5-year agreement guarantees Intrasense recurring revenues with this new partner.

Intrasense and DMS Group enter exclusive negotiations for the contribution of DMS Group medical imaging activities to Intrasense.

Intrasense announces its 2017 financial results and strategy for 2018.

Intrasense introduces Myrian^® new features and proves its seamless integration capabilities within any health information system.